Schedule 13G ownership disclosure

MBX Biosciences Inc

Security class unavailable · CUSIP: 55287L101

Event date: 2024-09-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,790,122
Percent of class
5.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001903360-24-000002
Form type
SC 13G
Filer
MBX Biosciences, Inc.
CIK
CIK 1776111
Filed
Sep 20, 2024
Reporting period
Sep 13, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub